As the COVID-19 outbreak has hit the Cincinnati area, many of our neighbors have required hospitalization for treatment of the virus.

 

The FDA has approved an Emergency Investigational New Drug (EIND) to allow the use of convalescent donor plasma.

 

Convalescent plasma is collected from recovered COVID19 patients who weeks earlier have been found cleared from the disease and found to have developed enough antibodies in their plasma.

Convalescent donor plasma may ameliorate the progression of the disease and even in some patients change significantly the outcome of the disease progression.

 

Hoxworth is seeking individuals who have had COVID-19 and have been symptom free for at least 28 days (or 14 days with one negative PCR test) to donate plasma. If you tested positive for COVID-19 and have been fully recovered for at least 28 days or 14 days with one negative PCR test, please CLICK HERE to visit Hoxworth Blood Center and complete the form.

If you are a physician, hospital representative or patient looking for more information, please email HoxCovid19@uc.edu.

 

Any testing performed for COVID-19 is for product management only. No results from any testing performed related to COVID-19 will be provided to donors. You should not attempt to donate to receive COVID-19 test results. They will not be provided.

 

For frequently asked questions and a signup form to donate convalescent plasma, please visit https://hoxworth.org/donors/eligibility/deferrals-restrictions/covid19plasma.html.

en English
X